Treating Laryngeal Hyperfunction With Flow Phonation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01988207 |
Recruitment Status : Unknown
Verified November 2013 by Gary H. McCullough, University of Central Arkansas.
Recruitment status was: Not yet recruiting
First Posted : November 20, 2013
Last Update Posted : November 20, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Muscle Tension Dysphonia | Behavioral: Vocal Hygiene Training Behavioral: Flow Phonation Exercises | Not Applicable |
All participants will complete the Evaluation Protocol at baseline, after 3 weeks (PERIOD 1),after 6 weeks (PERIOD 2), and for follow-up at 3, 6, and 12 months post-treatment. During PERIOD 1 (first 3 weeks), participants in ARM 1 will receive Vocal Hygiene Training as well as Airflow Exercise Training and participants in ARM 2 (the Control Arm) will receive only Vocal Hygiene Training. Vocal hygiene training alone has been demonstrated to have minimal impact on voicing32-34. During Period 2 (second 3 weeks), participants in BOTH ARMS will receive Vocal Hygiene Training and Airflow Exercise Training (Fig 3). Thus, participants in Arm 2 will receive no Flow Phonation for initial controlled comparison then 3 weeks of Flow Phonation for dose response comparison to Arm 1 (non-control) participants.
Assessment Protocol
Each participant will receive the Complete Evaluation Protocol at Baseline, after 3 weeks(PERIOD 1), after an additional 3 weeks (PERIOD 2), as well as at 3, 6, and 12 months posttreatment. These will include:
a. Laryngostroboscopic Examination b) Perceptual Voice Analysis/CAPE-V48-49 c) Acoustic Analysis/Computerized Speech Lab(CSL, KayPENTAX Corp) d) Aerodynamic Analysis/The KayPENTAX Phonatory Aerodynamic System (PAS) Model 6600 (KayPENTAX Corp.
e) Patients' Perception of Voice Handicap/Voice Handicap Index
Treatment Protocol Flow Phonation Each treatment session will take place in the same clinical room as the assessment and utilize three exercises: gargling, cup bubble blowing, and stretch and flow. Each exercise uses a built in form of biofeedback (water or tissue) and the same basic progression of activities (with minor alterations): 1) airflow task without voicing to establish positive airflow; 2) adding voicing to the task; 3) moving up and down the pitch range during the voicing task; 4) moving to a speaking/voicing task; and 5) removing biofeedback. During each vocalization attempt, the clinician listens for a clear and effortless vocal quality and trains the participant to listen.
Vocal Hygiene Training Vocal hygiene training centers on three factors: 1) hydration, 2) exogenous inflammation control, and 3) abstinence from yelling and screaming. Information will be provided initially as a Powerpoint presentation, during which each participant will have a manual and will write down answers to specific questions. Based on responses to the questions, the study clinician, in concert with the participant, will develop a set of recommendations for vocal hygiene. Examples of potential vocal hygiene targets are provided in Table 2. Three to five recommendations will be targeted for each participant, based on clinical judgment, although these numbers will serve only as a guide.
Participants will be provided a daily log to utilize where they can mark each target daily and make comments on how the target was met or not met. Each treatment session where Vocal Hygiene Training is targeted, alone or in concert with Airflow Training, participants will first present their goals, then provide the daily log and discuss successes and failures since the prior session. The study clinician and participant will then discuss the benefits of the successes and problem solve ways to improve upon failures.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Study Start Date : | December 2013 |
Estimated Primary Completion Date : | November 2016 |
Estimated Study Completion Date : | November 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: 12 Exercise Sessions
Patients will receive 12 treatment sessions with flow phonation exercises, as well as education on vocal hygiene.
|
Behavioral: Vocal Hygiene Training
Patients will receive education on how to care for their voices on three factors: 1) hydration, 2) exogenous inflammation control, and 3) abstinence of yelling and screaming. Behavioral: Flow Phonation Exercises Three exercises are employed: gargling, cup bubble blowing, and stretch and flow (tissue blowing). Each is done without voicing, with voicing, and then with variations in pitch and verbalization. |
Active Comparator: 6 Hygiene and 6 Exercise
Patients will receive 6 sessions of vocal hygiene training for initial comparison to patients in Arm 1. They will then receive 6 sessions of vocal exercise training and vocal hygiene training combined.
|
Behavioral: Vocal Hygiene Training
Patients will receive education on how to care for their voices on three factors: 1) hydration, 2) exogenous inflammation control, and 3) abstinence of yelling and screaming. Behavioral: Flow Phonation Exercises Three exercises are employed: gargling, cup bubble blowing, and stretch and flow (tissue blowing). Each is done without voicing, with voicing, and then with variations in pitch and verbalization. |
- Laryngeal Airway Resistance (Rlaw) Change Over Time [ Time Frame: 3 weeks, 6 weeks, 12 weeks, 6 months, 12 months ]Measured using the KayPENTAX Phonatory Aerodynamic System during a voice efficiency task (i.e., repeating "apapapapapapapa."
- Voice Handicap Index (VHI) [ Time Frame: 3 weeks, 6 weeks, 12 weeks, 6 months, 12 months ]The Voice Handicap Index is a 30 item questionnaire to assess the patient's perception of the impact of their voice on their quality of life and daily functioning.
- Consensus Auditory Perceptual Evaluation - Voice [ Time Frame: 3 weeks, 6 weeks, 12 weeks, 6 months, 12 months ]The CAPE-V is a perceptual measure of voicing made by the clinician to rate the patient's vocal quality on a 100 mm line scale.
- Noise-to-Harmonic Ratio [ Time Frame: 3 weeks, 6 weeks, 12 weeks, 3 months, 12 months ]The KayPENTAX Computerized Speech Lab will be used to record and analyze sustained phonation (AH) and provide a measure of noise to harmonic ratio.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Rlaw greater than 1 standard deviation above or below mean
- Voice Handicap Index of greater than 18
- CAPE-V severity of 20 or greater
- willing to sign informed consent
- women must not have experienced menopause or be pregnant
Exclusion Criteria:
- organic lesion of the vocal folds
- history of neurologic disease
- history of head and neck cancer
- pulmonary disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01988207
Contact: Gary H McCullough, Ph.D. | 501-450-3124 | gmccullough@uca.edu |
United States, Arkansas | |
University of Central Arkansas | |
Conway, Arkansas, United States, 72035 | |
Contact: Gary H McCullough, Ph.D. 501-450-3124 gmccullough@uca.edu |
Principal Investigator: | Gary H McCullough, Ph.D. | University of Central Arkansas |
Responsible Party: | Gary H. McCullough, Professor, Interim Dean of Graduate School, University of Central Arkansas |
ClinicalTrials.gov Identifier: | NCT01988207 |
Other Study ID Numbers: |
13-135 |
First Posted: | November 20, 2013 Key Record Dates |
Last Update Posted: | November 20, 2013 |
Last Verified: | November 2013 |
Muscle Tension Dysphonia Voice Hyperfunction |
Dysphonia Hoarseness Voice Disorders Laryngeal Diseases Respiratory Tract Diseases |
Otorhinolaryngologic Diseases Neurologic Manifestations Nervous System Diseases Respiration Disorders Signs and Symptoms, Respiratory |